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Renal kallikrein responses to dietary protein: A possible mediator of
hyperfiltration. We studied GFR, RPF and renal kallikrein in rats fed
9%, 25%, or 50% protein (casein) diets for 8 to 13 days. GFR and RPF
increased progressively with increasing dietary protein. Renal excretion
of active kallikrein (sg/day) was 128 9, 174 11 and 228 14 in 9%,
25%, and 50% protein-fed rats, respectively (P < 0.02 or less between
groups). Prokallikrein excretion in these groups was 23 7, 77 11 and
118 15 pg/day, respectively (P < 0.005 or less between groups). The
in vjvo renal kallikrein synthesis rate, relative to total protein synthesis,
was reduced in 9% protein-fed rats (2.74 0.24) compared to rats fed
25% (3.93 0.34, P < 0.02) or 50% protein (4.41 0.30, P < 0.001).
These changes in synthesis and excretion rates were not accompanied
by changes in renal tissue levels of active or prokallikrein. In all groups,
GFR and RPF correlated directly with the renal excretion of active
kallikrein, prokallikrein or total kallikrein (r = 0.41 to 0.66, P < 0.01).
Treatment of 50% protein-fed rats with aprotinin, a kallikrein inhibitor,
markedly lowered renal and urinary kallikrein-like esterase activity.
Left kidney GFR and RPF were significantly reduced in aprotinin-
treated rats compared to vehicle-treated rats (1.54 0.15 and 4.86
0.38 mI/mm vs. 1.89 0.10 and 5.93 0.22 mI/mm, GFR and RPF,
respectively, P < 0.05 or less). Protein-induced changes in renal
kallikrein synthesis and excretion could not be explained by changes in
aldosterone excretion, plasma renin activity, or electrolyte and water
intake or excretion. The data suggest that renal kallikrein and kinins
participate in mediating the renal vasodilatory effect of dietary protein.
In experimental animals and humans, an increase in glomer-
ular filtration rate (GFR) and renal plasma flow (RPF) can be
observed within hours of protein ingestion or intravenous
infusion of amino acids, and a sustained increase in the level of
dietary protein produces sustained increases in GFR and RPF
[1—8]. Recent studies in animals suggest that increased glomer-
ular capillary pressure, which accompanies some hyperfiltra-
tion states, may initiate glomerular damage and accelerate the
progression of glomerular diseases [9—12]. In these experimen-
tal models, reversal or prevention of hyperfiltration, or its
accompanying hemodynamic abnormalities, by dietary protein
restriction lessened glomerular structural damage [10, 11].
Dietary protein restriction may also retard the progression of
renal diseases in humans [13—15].
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For these reasons there is interest in understanding the
mechanisms and mediators of protein-induced changes in renal
hemodynamics. Micropuncture of single nephrons in normal
rats fed a protein-restricted diet shows that decreased GFR is
due to increased glomerular arteriolar resistance and reduced
glomerular plasma flow [11, 16]. Investigations of systemic and
renal vasoactive factors suggest that glomerular eicosanoids,
and the renin-angiotensin system may participate in altering
glomerular hemodynamics following manipulations of dietary
protein in normal animals and humans [8, 17—24], as well as in
renal disease states [18, 19, 25—27].
The role of renal kallikrein, and the vasoactive kinins it can
produce, in regulating renal hemodynamics is unclear [28],
However, recent localization of kallikrein in connecting tubule
cells adjacent to the afferent arteriole [291 and observations that
kallikrein inhibitors and kinin antagonists affect renal function
[30, 31] suggest that this enzyme and vasoactive peptide may
participate in regulating glomerular function, possibly modulat-
ing tubuloglomerular feedback [30]. Since tubuloglomerular
feedback is altered by changes in protein intake [32, 33], we
asked in the present study whether changes in protein intake are
associated with changes in renal kallikrein activity.
Methods
Animal protocols
Male Sprague-Dawley rats weighing 200 to 240 g were used in
all studies (Charles River Laboratories, Boston, Massachu-
setts, USA). Rats were housed four to five per cage, except
when 24-hour urine collections were obtained, when rats were
housed individually in metabolic cages (Nalgene Co., Roches-
ter, New York, USA). In all studies, rats were fed ad lib diets
containing 9%, 25% or 50% protein (U.S. Biochemical Corp.,
Cleveland, Ohio, USA). The dietary protein source was casein.
The change in protein content was offset by a change in
carbohydrate content (dextrose and cornstarch). Vitamins and
electrolytes were constant in the three diets; however, the 9%
diet was supplemented with methionine. Rats were fed one of
the three diets for 8 to 13 days.
In the initial study, urine was collected over the last 24 hours
before GFR and RPF were measured. Aliquots were stored at
—20°C until measurements of osmolality, sodium, potassium,
aldosterone and kallikrein were made. Following measurements
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Table 1. Effects of altered dietary protein on renal function
all comparisons
of GFR and RPF by a single-injection, single-sample isotopic
method, both kidneys were removed, perfused via the renal
hilum with 10 ml iced 0.9% saline, and stored at —20°C for
measurements of tissue kallikrein and protein.
In a subsequent study to assess the progression of changes in
renal excretion of kallikrein and aldosterone, and electrolyte
balance, 24-hour urine collections were obtained daily over 12
days from rats fed 9%, 25% or 50% protein. Food consumption
was measured daily to determine sodium and potassium intake.
Prior to the study, all rats were eating rat chow containing 24%
protein. Aliquots from each urine collection were stored at
—20°C until assays were performed. GFR and RPF were not
measured in these rats. Instead, at the end of 12 days the rats
were rapidly killed by decapitation and blood collected in
pre-chilled tubes containing EDTA for measurement of plasma
renin activity (PRA).
In separate groups of rats fed 9%, 25% or 50% protein for 12
to 13 days (N = 10 each), the in vivo renal kallikrein synthesis
rate was measured [34J. Each rat was injected i.p. with 35S-
methionine, 1 sCi/g body weight (translation grade, specific
activity >800 Ci/mmol, New England Nuclear, Bedford, Mas-
sachusetts, USA). Twenty minutes later the rats were anesthe-
tized with ether, the kidneys rapidly excised, perfused, and
stored as described above. Synthesis measurements were made
as described below.
The effects of a kallikrein inhibitor, aprotinin (Bayer A.G.,
Wuppertal, FRG), on GFR, RPF, and renal and urinary kal-
likrein activity were studied in rats fed 50% dietary protein for
12 days. During the last three days of the study, rats received
twice-daily subcutaneous injections of aprotinin (17,500 KIU)
or vehicle (0.1 ml 0.9% saline, containing 0.9% benzyl alcohol).
Left kidney GFR and RPF were measured at the end of this
period by direct clearance methods. Thirty minutes prior to
measuring GFR and RPF, aprotinin-treated rats were given an
intravenous dose of aprotinin (20,000 KIU/kg) and this was
followed by an infusion of 2,000 KIU/kg/min, which continued
during the measurement period. Immediately thereafter, kid-
neys were excised, perfused and stored for measurement of
tissue kallikrein-like esterase activity and protein. GFR and
RPF were concomitantly measured in a control group of rats fed
25% protein for 12 days.
GFR and RPF measuretnents
Animals were anesthetized with mactin (Byk Gulden, Kon-
stanz, FRG), 80 mg/kg i.p., and placed on a thermo-regulated
warming pad, adjusted to maintain rectal temperature at 37°C.
To measure GFR and RPF by the single-injection, single-
sample isotopic method without urine collection [35], rats were
injected via tail vein with 5 Ci of 51Cr-EDTA (New England
Nuclear) and 5 Ci '251-orthoiodohippuran (Amersham, Arling-
ton Heights, Illinois, USA). A plasma sample was obtained by
cardiac puncture 60 minutes later and counted for 51Cr and 1251.
The clearances of these isotopes were calculated from the
plasma activity and their volume of distribution. Volume of
distribution of each isotope was calculated from rat body weight
using an algorithm derived from the study of a large group of
acutely nephrectomized Sprague-Dawley rats, fed 25% protein
[35]. To determine if dietary protein content influenced isotope
distribution, the volumes of distribution of 'Cr-EDTA and
'251-hippuran were measured in preliminary studies in rats fed
9%, 25% or 50% protein diet (N = 8 to 10 each). These
distribution volumes, expressed as % body weight, were not
significantly different in rats fed 9% or 50% protein, compared
to rats fed 25% protein (51Cr-EDTA: 22.9, 23.2, 22.5; and
'251-hippuran: 28.5, 30.1, 29.8, in rats fed 9%, 25% and 50%
protein, respectively).
Measurements of GFR and RPF by direct clearance studies
were carried out in rats anesthetized and thermo-regulated as
above, and prepared as follows: Tracheostomy was performed,
and the left ureter was cannulated with a PE 10 cannula for
urine collection. The left femoral artery was cannulated for
blood sampling and direct monitoring of blood pressure via a
pulse transducer. Plasma loss from surgery was replaced with
isoncotic plasma (1% body weight) obtained from donor rats fed
identical protein diets. Plasma was infused via tail vein over 30
to 40 minutes, followed by intravenous infusion of 0.9% saline
(2.8 ml/hr). To measure GFR and RPF, 6 pCi 51Cr-EDTA and
1,5 pCi '251-orthoiodohippuran, respectively, were given as i.v.
boluses, followed by an infusion of 10 uCi/hr 51Cr-EDTA and
2.5 pCi/hr '251-hippuran, Both isotopes were diluted in the
saline infusate, such that the total fluid delivered was 2.8 ml/hr.
After 60 minutes, urine was collected for two 30-minute periods
in pre-weighed tubes kept at 4°C. Blood (200 .d) was sampled
from the femoral artery at the mid-point of each urine collection
for measurement of hematocrit, plasma protein and plasma
radioactivity. Blood was replaced with an equal volume of
plasma. Urine and plasma radioactivity were used to calculate
clearances.
Kallikrein assays
Kidney tissue was prepared for assay as previously described
[36]. Briefly, kidneys were minced and homogenized in 5 ml
Dietary
protein
%
GFR RPF GFR RPF
Body
wt Kidney wt Urine vol
mI/day
UNaV UKV
mi/mm mi/minig kidney g mEqlday
9 1.92 0,05b 4.47 0.15° 0.88 0.03 2.05 0.07 240 3" 2.19 O.O51 12.8 1.5" 3.54 0.37 1.42 0.09
N = 14
25 2.34 0.08 5.26 0.16 0.90 0.03 2.01 0.05 282 6 2.62 0.07 23.8 3.0 3.71 0.24 1.76 0.13
N = 12
50 2.75 0.11" 5.29 0.16 0.99 0.04° 1.89 0.06 275 5 2.83 0.10 30.7 2.5 3.89 0.17 1.84 0.07
N = 16
Values are expressed as mean SE.
a p < 0.05, b P < 0.005, P < 0.002; dP < 0,001 vs. 25% group for
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Table 1. Extended
C'Osm
pd/mm
'DNa 1f( pprotein
g/100 in!mEq/!iter
30 2 145 1 5.2 0.1 7.1 0.2"
64 4 146 1 4.9 0.2 8.0 0.2
121 4d 145 I 4.7 0.1 8.0 0.2
phosphate buffered saline, pH 7.4, with a teflon/glass homoge-
nizer. Sodium deoxycholate (0.5%, final concentration) was
added to the homogenate, and after incubation at 4°C for 60
minutes, the homogenate was centrifuged (25,000 g) at 4°C for
45 minutes. The resulting supernatant was then centrifugally
filtered through Sephadex G-25 (Pharmacia, Piscataway, New
Jersey, USA) to remove salts and excess detergent, and the
filtrate was used for assay of immunoreactive kallikrein, kal-
likrein-like esterase activity and protein. Urine was assayed
directly without extraction or desalting.
Active kallikrein and prokallikrein levels were measured with
a radioimmunoassay that uses a monoclonal antibody specific
for active tissue kallikrein [371. As described previously [36],
active kallikrein was measured directly, and total kallikrein was
measured in a second sample aliquot, in which prokallikrein
was converted to active kallikrein by prior trypsin treatment
and subsequent inhibition of trypsin with soybean trypsin
inhibitor. Prokallikrein concentration was derived by subtract-
ing the directly measured active kallikrein from total kallikrein.
Kallikrein-Iike esterase activity in kidney tissue homogenate
and urine was measured according to the method of Beaven,
Pierce and Pisano [38], using 3H-tosyl-arginine methyl ester
substrate.
Kallikrein synthesis
The in vivo synthesis rate of renal kallikrein, relative to
synthesis of total protein, was determined by measuring the
incorporation of 35S-methionine into kallikrein and total renal
protein, as previously described by Miller, Chao and Margolius
[34]. Rats were injected with the amino acid label, as described
above, and after 20 minutes kidneys were removed, perfused
and homogenized as described for the kallikrein assays. Kal-
likrein was immunoprecipitated from the kidney homogenate
supernatant with a sheep polyclonal anti-kallikrein antiserum.
Total protein was precipitated from an identical aliquot with
trichioroacetic acid. The radioactivity of these precipitates was
measured by liquid scintillation spectrometry and the relative
kallikrein synthesis rate calculated as the ratio of cpm in
kallikrein/mg protein to cpm in total protein/mg protein.
Other assays
Urinary aldosterone was measured by a commercial radioim-
munoassay kit (Diagnostic Products, Los Angeles, California,
USA). PRA was measured as generated angiotensin I, using a
kit (E.R. Squibb Diagnostics, New Brunswick, New Jersey,
USA). Generation of angiotensin I was carried out by adding
0.1 ml of renin substrate (plasma from rats nephrectomized for
24 hr) to 0.5 ml of the plasma sample, followed by incubation at
37°C for 30 minutes [39]. Angiotensin I generation during the
incubation period was linear, and nephrectomized rat plasma
did not generate angiotensin I. Activity was corrected for
dilution of the sample with substrate plasma, and PRA was
expressed as ng Al/mi plasmalhr incubation. Tissue homoge-
nate and plasma protein were measured by the method of
Lowry [40], using bovine serum albumin as standard. Urine and
plasma sodium and potassium were measured by flame photom-
etry using an 1L943 analyzer (Instrumentation Laboratories,
Newton, Massachusetts, USA). Urine and plasma osmolality
were measured with a vapor pressure osmometer (Wescore,
Ogden, Utah, USA).
Statistical methods
Data are expressed as mean SEM. Data were analyzed by
univariate analysis of variance, using the statistics package
BMDP lv, or analysis of variance and covariance with re-
peated measures, using BMDP 2V [41]. In the former, pair-wise
t-tests were used to compare groups when a significant differ-
ence was found. Within each study the Bonferroni correction
was used to guard against type I error due to multiple analyses.
Results
Renal function in relation to dietary protein
Measurements by the single-injection method showed that
GFR was decreased in rats fed 9% protein and increased in rats
fed 50% protein, compared to 25% protein-fed rats (Table 1).
Reduced GFR in the 9% group was associated with reduced
RPF, but RPF was not increased in the 50% group. Subsequent
direct clearance measurements showed increased RPF and
GFR in 50% versus 25% protein-fed rats (Table 2). When renal
function was expressed relative to kidney weight, GFR was still
significantly higher in 50% protein-fed rats, compared to the
other groups; however, there were no differences in RPF.
With dietary protein increasing from 9% to 50%, there was an
increase in the urine volume and osmolar clearance, measured
on the final study day (Table 1). Excretion of sodium and
potassium on the same day were unchanged. Plasma sodium
and potassium concentrations were not significantly different in
the three groups. Plasma protein concentration was reduced in
rats fed 9% protein, compared to rats fed 25% or 50% protein.
Effects of dietary protein on renal kallikrein
Figure 1 shows the excretion rate of prokallikrein, active
kallikrein and total kallikrein during the 24-hour period prior to
measurement of renal function. All fractions of kallikrein were
significantly increased with increasing dietary protein. In rats
fed 50% protein, active kallikrein excretion was nearly twofold,
and total kallikrein was more than twofold, the excretion rate in
rats fed 9% protein. Prokallikrein excretion was increased more
than fivefold in 50% compared to 9% protein-fed rats. If
excretion rates were expressed relative to body or kidney
weight, all of the differences remained statistically significant.
Kallikrein excretion rates correlated directly with GFR and
RPF. Figure 2 shows excretion rate of total kallikrein, as the
independent variable, plotted against GFR (r = 0.66, P <
0.001). A similar significant correlation was found between total
kallikrein and RPF (r = 0.66, P < 0.001). Active kallikrein
excretion also correlated significantly with GFR and RPF (r =
. 300-
I0S
C
Prokallikrein Active kallikrein Total kIlikrin
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Table 2. Effects of aprotinin on renal fu nction and kallikrein activity
Renal
Dietary
protein
%
GFR RPF GFR RPF Kidney wt
g
MBP
mm Hg
Uvoiume
.d/min
Utra
mEUlmin
esterase
mEU/g
proteinmI/mm ml/min/g kidney
50% + vehicle 1.89 0.10 5.93 0.22 1.08 0.05 3.39 0.09 1.75 0.04 95 4 8.4 1.0 4.36 0.60 732 69
N = 10
50% + aprotinin 1.54 o.lsa 4.86 038b 0.86 0.09a 2.70 023b 1.82 0.06 101 4 12.1 2.3 0.23 0.04" 63 4"
N= 9
25% + vehicle 1.56 0.05k' 5.07 O.ISC 1.05 0.05 3.41 0.12 1.50 0.07c 102 8 8.9 2.7 — —N= 7
Values are expressed as mean SE. Left kidney function was measured.
P <0.05; b P C P <0.01;" P <0.001 vs. 50% + vehicle
Fig. 1. Renal excretion of prokallikremn, active kallikrein and total
kallikrein in rats fed varying levels of dietary protein. Rats were fed the
diet for 8 to 13 days and excretion rates measured on the final day
preceding measurements of GFR and RPF. Excretion in 9% (,N =
14) and 50% (, N = 16) groups are compared to excretion in the 25%(•, N = 12) group. *P < 0.05; tP < 0.02; §P < 0.005; 1P < 0.001.
0.41 and 0.48, respectively, P < 0.01 both), as did prokallikrein
(r = 0.65 and 0,65 for GFR and RPF, respectively, P < 0.001
both).
To assess further how changes in dietary protein affect
kallikrein excretion, urinary active and prokallikrein (pg/day)
were measured daily for 12 days in separate groups of rats fed
9%, 25% or 50% protein (N = 6 to 7 each). Prior to the study,
all rats were eating rat chow containing 24% protein. As shown
in Figure 3, excretion of active kallikrein (solid symbols)
increased from day 1 to day 12 in both 25% protein-fed rats
(squares: 133 19 vs. 158 13 p.g/day, P < 0.006) and 50%
protein-fed rats (circles: 120 19 vs. 197 24 pg/day, P <
0.001). However, the rate of increase was significantly greater
in rats fed 50% protein compared to rats fed 25% protein (P <
0.004). Rats fed 9% protein showed no significant change in
urinary active kallikrein over 12 days (triangles: 102 14 vs.
125 14 pg/day).
Prokallikrein excretion (open symbols) contrasted with ex-
cretion of active kallikrein. From day I to day 12, 9% and 25%
protein-fed rats showed a significant fall in urinary prokallikrein
(9%: 59 4 vs. 10 3 rig/day, P < 0.001; 25%: 101 4 vs. 60
7 pg/day, P < 0.001). The fall in prokallikrein was more
marked in rats fed 9% protein, and excretion rate in this group
was consistently lower over the 12 days than rats fed 25%
protein (P < 0.001). After day 6, more than half of the rats fed
9% protein showed days in which no urinary prokallikrein was
excreted. Prokallikrein excretion in 50% protein-fed rats did not
fall significantly (80 6 vs. 53 14 tg/day, NS).
Although there were consistent changes in urinary kallikrein
excretion, renal tissue levels of active and prokallikrein were
not altered by changes in dietary protein intake. In rats fed 9%,
25% or 50% protein for 8 to 13 days (kallikrein excretion rates
as shown in Fig. 1), renal tissue prokallikrein levels were 27.2
3.7, 28.6 3.5 and 31.6 1.5 nglmg protein, respectively;
active kallikrein levels were 54.7 4.2, 46.0 3.9 and 47.6
3.7 nglmg protein. Similar levels were observed in rats in which
kallikrein synthesis was measured. Despite this lack of change
in tissue kallikrein levels, there was a clearly detectable change
in renal kallikrein synthesis rate. The synthesis rate (l0 x
kallikrein cpm/total protein cpm) in rats fed 9% protein was 2.74
0.24, compared to 3.93 0.34 in rats fed 25% protein (P <
0.02). Synthesis rate in the 50% protein group (4.41 0.30) was
not significantly greater than in the 25% group, but was in-
creased compared to the 9% group (P < 0.001).
Aldosterone, plasma renin activity and electrolyte balance
In the initial groups of rats, studied after 8 to 13 days of
differing dietary protein content (Table 1), urinary aldosterone
excretion was increased on the final day in rats fed 50% protein.
In this group, urinary aldosterone was 15.1 1.7 ng/day,
compared to 7.2 0.8 ng/day in rats fed 25% protein (P < 0.02).
There was no significant change in the 9% group (4.7 0.3
nglday), compared to 25% protein-fed rats. Because of this
finding, and because urinary sodium and potassium excretion
on the final day tended to be greater in rats fed higher protein
(Table 1), we measured daily intake and excretion of sodium
and potassium in relation to kallikrein excretion in the three
groups over 12 days (c.f. kallikrein in Fig. 3). Plasma renin
activity was also measured at the end of the 12-day period in all
groups, and aldosterone excretion was measured daily in the
50% protein-fed group, to more closely assess aldosterone in
relation to the kallikrein changes.
Over the 12 days, average sodium excretion was 3.94 0.07
and 3.74 0.09 mEq/day in rats fed 50% and 25% protein,
respectively (NS). Excretion in rats fed 9% protein was less
(2.59 0.05 mEq/day, P < 0.001 vs. 25% or 50%). Potassium
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Fig. 2. Correlation between excretion rate of
total kallikrein and GFR in rats fed 9% (A),
25% (0) or 50% (•) protein. A similar
_____________________________________ significant correlation was found between total
500 550 kallikrein and RPF, as well as between active
or prokallikrein and GFR or RPF (see text for
correlation coefficients).
excretion in 50% and 25% protein groups was also greater than
in the 9% group (1.87 0.07 and 1.77 0.02 vs. 1.47 0.05
mEq/day, P < 0.001 vs. either). These differences in electrolyte
excretion paralleled differences in intake, as assessed by daily
food consumption. Therefore, the balances between intake and
excretion were not different among any of the groups for either
sodium or potassium. As predicted from the first study, aldo-
sterone excretion rate was increased on day 12, compared to
day 1, in rats fed 50% protein. However, this increase was
sporadic from day 6 to 12 and did not precede or coincide with
the sustained increase in excretion of active kallikrein, which
was significant from day 6 through 12 (Fig. 3). Furthermore,
plasma renin activity was not significantly different among the
groups at the end of the 12 days (27,1 3.8, 28.7 1.1 and 34.9
3.4 nglml/hr in 9%, 25% and 50% groups, respectively).
Rena/function in aprotinin-treated rats
Rats fed 50% protein for 12 days were treated on the last
three days with aprotinin (N = 9) or vehicle (N = 10). Urinary
and renal kallikrein-like esterase activity were markedly re-
duced in aprotinin-treated rats compared to levels in vehicle-
treated rats (Table 2). Aprotinin treatment lowered GFR and
RPF proportionally in 50% protein-fed rats to levels not dif-
ferent from those in rats fed 25% protein. Calculated renal
vascular resistance, which was lower in 50% versus 25% rats
(8.3 0.5 vs. 10.4 0.7 mm Hg/mt/mm, P < 0.02), was raised
by aprotinin treatment (11.5 1.5, P < 0.05 vs. vehicle-treated
50% rats). Blood pressure, plasma protein concentration, he-
matocrit and urine volume during measurement of GFR and
RPF were not different in 50% versus 25% rats and were not
altered by aprotinin treatment. Aprotinin also had no effect on
24-hour urine volume, osmolality, sodium or potassium excre-
tion.
Discussion
In the present study we found: that increasing dietary protein
increases renal synthesis of prokallikrein, as well as the excre-
tion of both active kallikrein and prokallikrein; that over a wide
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Fig. 3. Effect of changing the dietary protein level on the excretion
rates of active and prokallikrein. Excretion rates of active kallikrein
(solid symbols) and prokallikrein (open symbols) are plotted for rats fed
9% protein (triangles), 25% protein (squares), or 50% protein (circles).
Prior to day I all rats were fed a 24% protein diet. Over 12 days active
kallikrein increased significantly in both 25% (P < 0.006) and 50%
protein-fed rats (P < 0.001), but the rate of increase was greater in the
50% group (P < 0.004). Prokallikrein excretion fell significantly in 25%
and 9% protein-fed rats (P < 0.001 in both).
2 4 6 8 10 12
Day
1008 Jaffa et a!: Renal kallikrein and dietary protein
range of protein intake the excretion rates of active and
prokallikrein correlate with GFR and RPF; and both GFR and
RPF can be reduced in rats fed high protein diet by treatment
with a kallikrein inhibitor.
The findings also suggest that activation of prokallikrein, as
well as its synthesis, is influenced by the level of protein intake.
When protein intake was raised from 24% to 50% (Fig. 3), there
was a progressive increase in active kallikrein excretion without
an increase in prokallikrein excretion, suggesting that increased
synthesis was coupled with increased conversion of zymogen to
active kallikrein. In contrast4 when protein intake was reduced
to 9% and kallikrein synthesis was reduced, the rate of active
kallikrein excretion was preserved in the face of a marked fall in
urinary prokallikrein. In spite of this, urinary active kallikrein
fell below that of rats fed normal or high protein.
While renal synthesis and excretion were profoundly
changed, neither active nor prokallikrein tissue levels changed
in relation to protein intake. Protein labelling studies show that
kallikrein in the kidney displays a very rapid turnover rate
relative to total renal protein [34], and this is consistent with the
observation that the quantity of kallikrein excreted daily repre-
sents 40- to 50-fold the total renal content [361. If there is little
storage, kallikrein's activity in the kidney may be better re-
flected in its synthesis or excretion rate than by a single static
measurement of tissue level. On the other hand, it is possible
that changes in excretion rate maintain constant renal activity
despite increased or decreased synthesis. Some support for the
interpretation that renal activity is changed by the level of
protein intake comes from our observation that renal kinin
excretion changes. Renal kinin excretion iP 50% protein-fed
rats is fivefold the level in 9% rats (17.2 7.1 vs. 3.3 0.5
pg/mm/kidney, P < 0.001).
Other system components, kininogen substrate and ki-
ninases, which we did not measure in this study may also
regulate kallikrein-kinin system activity in the kidney. In this
regard, we recently observed that protein restriction increases
total renal kininase activity, a change which could also contrib-
ute to a reduction in kinins (unpublished data). Together with
the present results of functional studies, all of the data are
consistent with the notion that the vasodilator activity of the
renal kallikrein-kinin system is altered by the level of protein
intake.
Effects of dietary protein on tissue kallikreins have been
examined in at least three previous studies, with only one of
these finding an effect on renal kallikrein. Frey, Kraut and
Werle [43] observed many years ago that humans and rats fed
meat or eggs excreted more kallikrein-like esterase activity in
the urine than during a high fat or normal diet. In contrast, the
excretion of urinary kallikrein-like esterase activity was un-
changed in vegetarian humans during four weeks in which 250 g
of beef was introduced into their daily diet [44]. However, total
protein content was not controlled in the diets of these subjects,
who were eating fish and eggs prior to study. Kojima and Ito
[451 reported that increasing dietary protein from 10% to 40% in
rats on a high salt diet tended to increase urinary kallikrein
activity, as measured with a chromogenic substrate, but the
increase was not significant, and they did not observe an
increase in creatinine clearance.
The reasons for increased renal kallikrein synthesis and
excretion in response to dietary protein are uncertain. Mm-
eralocorticoid, either exogenously administered or endoge-
nously raised by dietary sodium deprivation, can raise urinary
kallikrein [28, 46, 471. We observed increased urinary aldoste-
rone excretion in rats fed 50% protein, but this followed the
increase in kallikrein and was not persistent over the time
kallikrein excretion increased. Furthermore, aldosterone excre-
tion was not significantly different between rats fed 9% and 25%
protein, but kallikrein excretion and synthesis were. Although
sodium and water excretion were greater in 25% and 50%
groups, compared to 9%, this was associated with greater
sodium intake, Together with lack of a difference in PRA
between groups, it does not suggest that sodium or volume
depletion were responsible for increased kallikrein. Our data
contrast with other recent studies which found increased PRA
in rats fed high versus low protein [21, 48]. However, in one of
these studies the rats were pair-fed [21], and in neither did
sodium excretion differ between groups. Rats in our study were
fed ad lib and those on higher protein consumed more sodium.
This may account for the differences in PRA between ours and
previous studies.
Potassium intake in our study was also greater in rats fed
higher protein, and increased potassium intake is associated
with increased excretion of kallikrein-like esterase activity in
humans, but this change is thought to be aldosterone mediated
[49]. Higher potassium intake could explain the increase in
aldosterone excretion in 50% protein-fed rats that did not show
higher PRA.
Osmolar clearance increased as dietary protein increased,
likely the result of increased urea excretion. Some evidence
suggests that osmotic diuresis transiently increases urinary
kallikrein levels due to washout [50]. However, renal and
urinary kallikrein have been examined in only one other state in
which there is a chronic osmotic diuresis. Diabetic rats with
marked osmotic diuresis show decreased renal and urinary
kallikrein [51]. Thus, it is difficult to attribute protein-induced
changes in kallikrein to osmotic effects alone.
Some data suggest that insulin, glucagon and growth hor-
mone, in some combination play a role in mediating the filtration
response to amino acids and protein [52]. In the present study,
the a.m. plasma insulin level was decreased in rats fed 9%
protein compared to rats fed 25% or 50% protein (13.2 5.1,
vs. 43.8 9.4 and 40.7 5.5 tU/ml, P < 0.005). Reduced
plasma insulin levels in rats fed low protein diets have also been
observed in previous studies [53, 54]. We previously showed
that insulin is an in vivo regulator of renal prokallikrein synthe-
sis and activation [36], and preliminary studies using the strep-
tozotocin-diabetic rat suggest that eliminating endogenous in-
sulin production eliminates the ability of kallikrein to respond to
increased dietary protein (unpublished observations). Together
these findings suggest that insulin may participate in mediating
kallikrein responses to protein.
The direct correlation between kallikrein excretion rate and
GFR or RPF, and the proportional reductions in GER and RPF
in 50% protein-fed rats following aprotinin treatment suggest
that kallikrein and/or kinins may mediate changes in intrarenal
hemodynamics induced by dietary protein. In our initial study,
using the single-injection method to study hydropenic rats
(Table 1), RPF was not increased in parallel with GFR between
50% and 25% groups. However, direct clearance measurements
in euvolemic rats showed proportional increases in GFR and
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RPF between these groups (Table 2). Several studies have
found that GFR and RPF are reduced in protein-restricted rats
compared to high protein-fed rats [10, 11, 16, 211, but the effect
of increasing protein above the usual rat dietary level of 20 to
25% has not been closely examined. In a study of dietary
protein effects in diabetic rats, Mauer et at [55] recently
reported that increasing from 20% to 50% protein raised both
GFR and RPF in normal rats.
In several of these studies as well as in our study, changes in
GFR or RPF were accompanied by proportional changes in
kidney weight [10, 11, 55], raising the question of whether the
changes in function are the result of changes in kidney size. At
least two observations suggest this is not the case. First,
Ichikawa et al observed differences in whole kidney and single
nephron GFR and plasma flow between rats fed 6% or 40%
protein ad lib, despite no difference in kidney weight [16].
Second, a recent study demonstrated that increasing protein
intake from 21% to 50% inyoung rats increases SNGFR prior to
any detectable change in glomerular growth, assessed by thy-
midine incorporation [56]. In any case, over a range from low to
high protein intake, changes in single nephron function appear
to be reflected by the absolute whole kidney GFR and RPF
rather than levels normalized by kidney weight [1.1].
Several observations support the notion that the kallikrein
changes we discovered are relevant to the renal hemodynamic
changes induced by protein. First, careful immunocytochemical
studies in the rat by Barajas et a! [29] showed that kallikrein-
containing cells of the distal connecting tubule pass immedi-
ately adjacent (<S j.) to the afferent arteriole. Furthermore,
electron microscopic immunocytochemistry demonstrates that
kallikrein traffics to the basolateral as well as lumenal mem-
brane of these cells [57]. Second, physiologic levels of kinin can
reduce resistance in the rat afferent arteriole when the kinin is
applied to the antilumenal side [58]. Finally, studies by Schner-
mann et al [30] on the effects of aprotinin and captopril on
tubuloglomerular feedback suggest that increased kallikrein-
kinin system activity may reduce the sensitivity of feedback.
Seney and Wright found that tubuloglomerular feedback sensi-
tivity is reduced in rats with protein-induced hyperfiltration
[32]. Our findings raise the possibility that this change may be
related to increased kallikrein activity in these rats.
Conclusions must be drawn cautiously from the responses
observed to aprotinin administration. Aprotinin is a nonspecific
serine protease inhibitor and is also a cationic peptide, and its
effects could be through an action other than kallikrein inhibi-
tion. While there is no evidence that other serine proteases
known to be inhibited by aprotinin have any role in renal
function, immunohistochemical localization with anti-aprotinin
antiserum does reveal that a considerable amount of aprotinin
reaches the kallikrein-producing region of the distal nephron in
the 50% protein-fed rats treated with aprotinin (personal com-
munication, Dr. Carlos Vio). Moreover, we recently observed
that the action of aprotinin in blocking the renal vasodilatory
response to amino acid infusion in rats can be reproduced by
infusing a kinin receptor antagonist [42, 591.
Studies of glomerular microhemodynamic responses to spe-
cific kallikrein inhibitors and kinin antagonists should provide
more direct insight into the role of kallikrein and kinins in
mediating the effects of protein and amino acids. However, it is
of interest that the present findings in the rat have been
confirmed recently in humans. In normal subjects, increased
active and prokallikrein and kinin excretion precede a rise in
GFR within a few days of raising protein intake [60]. Whatever
the mechanisms for these changes and whatever their effects,
the response of the renal kallikrein-kinin system to dietary
protein seems consistent.
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